中药复方制剂脂欣康胶囊预防兔颈动脉粥样硬化斑块形成及其网络药理学与生物学机制研究
该研究在颈动脉套管植入联合高脂饮食兔模型中验证脂欣康胶囊(ZXC)抗动脉粥样硬化斑块形成的效果。185 mg/kg ZXC可显著抑制斑块形成、减轻内膜增厚、降低血脂并升高血浆IL-4。研究鉴定23种入血成分,网络药理学与生物学实验提示山奈酚、大豆苷元、葛根素、丹参酮及水蛭和JUN、FOS、TP53靶点参与其活性。
要点
- ZXC 185 mg/kg可显著抑制兔颈动脉斑块形成和内膜增厚。
- ZXC可降低血脂并升高血浆IL-4水平。
- 山奈酚、大豆苷元、葛根素、丹参酮及JUN、FOS、TP53可能为关键活性成分与靶点。
核心结论
- 在当前临床剂量下,ZXC可预防颈动脉粥样硬化斑块形成和内膜增厚。
研究设计与样本
- 研究采用颈动脉套管植入联合高脂饮食12天的兔模型,ZXC灌胃剂量为185 mg/kg和370 mg/kg。
- 采用UPLC-QTOF-MS鉴定ZXC入血成分,并结合网络药理学预测和生物学实验验证关键成分与靶点。
主要发现
- 与溶媒对照组相比,ZXC 185 mg/kg可显著抑制套管植入颈动脉的斑块形成并减轻内膜增厚。
- ZXC 185 mg/kg可显著降低兔血脂水平并升高血浆IL-4水平。
- 共鉴定23种入血成分,山奈酚、大豆苷元、葛根素、丹参酮及水蛭和JUN、FOS、TP53靶点被识别为ZXC生物活性的重要参与者。
临床怎么用
- 基于动物实验证据,ZXC在当前临床剂量下可能用于预防颈动脉粥样硬化斑块形成和内膜增厚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Chinese patent medicine Zhixiong Capsule (ZXC) has been used in clinical treatment against blood stasis-induced dizziness and headache for many years in China. HYPOTHESIS/PURPOSE: Recent clinical observations demonstrated a good efficacy of ZXC against atherosclerotic plaque formation in carotid arteries. The aims of this study were to verify the plaque-preventing efficacy of ZXC in animals and to investigate the underlying mechanisms. STUDY DESIGN/METHODS: ZXC (185 mg/kg and 370 mg/kg) was administrated to rabbits which received collar implantation accompanied with high fat diet administration (12 days). The blood-dissolved components of ZXC were identified by an UPLC-QTOF-MS method. The key components and targets of ZXC were then predicted based on network pharmacology analysis and biological investigations. RESULTS: Compared with vehicle control group, ZXC administration (185 mg/kg) significantly prevented plaque formation and attenuated intima thickening in the collar-implanted carotid arteries, markedly decreased blood lipid level, and increased plasma IL-4 level in rabbits. A total of 23 blood-dissolved components were identified. Four ingredients (namely, kaempferol, daidzein, puerarin, miltirone) along with leech, and three targets (namely, JUN, FOS and TP53) were recognized to play important roles for ZXC bioactivity. CONCLUSION: It could be concluded that ZXC could be applied to prevent atherosclerotic plaque formation and intimal thickening in carotid arteries at the current clinical dose.
引用
- Zhai J, Song Z, Wang Y, et al. Zhixiong Capsule (ZXC), a traditional Chinese patent medicine, prevents atherosclerotic plaque formation in rabbit carotid artery and the related mechanism investigation based on network pharmacology and biological research. Phytomedicine. 2018. PMID: 31004886. doi:10.1016/j.phymed.2018.11.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。